Case Study: Neuropsychopharmacology

1005 Words5 Pages
Module Title: Neuropsychopharmacology
Module Code: A8PS102
Programme: BA (Hons) in Psychology
Delivery Mode: FT PT

Lecturing Team Name Email Telephone
Module Leader: Tergel Khashbat 10170423@dbs.ie

Indicative Timetable Full time Part time Monday at 10am – 12am Monday 6.00pm – 7.00pm Wednesday 9am -11am
Duration 4 weeks

Module objectives:

1. To build learners knowledge and understanding of the brain anatomy from the cellular to gross understanding, the neurotransmitter system and its function of the role of behaviour.
2. To teach learners the important principle of pharmacology such as how drugs affect human body and brain, what the drug does to the body and what the body does to the drug.
3. To give more understanding of how
…show more content…
Learners will have an understanding about the basic and essentials of neuro psychopharmacology such as from target selection to treatment using drugs, evaluate its efficacy and implications in humans and animals. Learners will have developed full understanding of number of neurobiological and psychiatric disorder’s causes and range of treatments and lastly how certain drugs can alter the mood and behaviour of the user.

Learning Activities:

The neuropsychopharmacology module will be assessed by two components which will consist of continuous assessment in the form of a detailed essay about a chosen neurobiological disorder, stating its symptoms, causes and treatments with a drug of choice detailing the mechanism of its action from a cellular level. Students are required to provide detailed overview of the chosen disorder by identifying the system and structures that’s involved in it. Students must have published research referenced in the essay (50% of final grade) and an in class test at the end of the 4 weeks. The examination will consist of diagrams, short answer questions and multiple choice questions that will address the contents that have been covered since week 1 (50% of the final
…show more content…
Drug manufacture and animal model. Will be discussing the current strategies of drug development and its uses for the treatment of number of psychiatric and neurobiological disorders such as parkinson’s, alzheimer’s, schizophrenia, depression, anxiety etc. Ethical debates and implication of preclinical experiments involving the use of animal models and its efficacy will be debated in the classroom.
Week 3
5. Antipsychotic drugs. The historical background of the antipsychotic drugs including when who and how it was developed originally and how it has since been improved. The mechanism of its action and application of antipsychotic drugs for psychiatric disorder such as schizophrenia will be discussed.
6. Antidepressant drugs. The historical background of the antidepressant drugs including when who and how it was developed originally and how it has since been improved. The mechanism of its action and application of antipsychotic drugs for it’s psychiatric disorder depression will be discussed.
Week 4
7. Anxiolytic drugs. The historical background of the anxiolytic drugs including when who and how it was developed originally and how it has since been improved. The mechanism of its action and application of antipsychotic drugs for its psychiatric disorder anxiety will be
Open Document